CA2370784C - Endodontic fibers and methods of use therefor - Google Patents

Endodontic fibers and methods of use therefor Download PDF

Info

Publication number
CA2370784C
CA2370784C CA2370784A CA2370784A CA2370784C CA 2370784 C CA2370784 C CA 2370784C CA 2370784 A CA2370784 A CA 2370784A CA 2370784 A CA2370784 A CA 2370784A CA 2370784 C CA2370784 C CA 2370784C
Authority
CA
Canada
Prior art keywords
endodontic
fiber
treatment
fibers
intracanal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2370784A
Other languages
English (en)
French (fr)
Other versions
CA2370784A1 (en
Inventor
Jack Gilad
Philip Stashenko
Max Goodson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
ADA Forsyth Institute Inc
Original Assignee
Forsyth Dental Infirmary for Children Inc
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forsyth Dental Infirmary for Children Inc, Harvard University filed Critical Forsyth Dental Infirmary for Children Inc
Publication of CA2370784A1 publication Critical patent/CA2370784A1/en
Application granted granted Critical
Publication of CA2370784C publication Critical patent/CA2370784C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
CA2370784A 1999-04-02 2000-03-30 Endodontic fibers and methods of use therefor Expired - Fee Related CA2370784C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12749799P 1999-04-02 1999-04-02
US60/127,497 1999-04-02
PCT/US2000/008582 WO2000059469A2 (en) 1999-04-02 2000-03-30 Endodontic fibers and methods of use therefor

Publications (2)

Publication Number Publication Date
CA2370784A1 CA2370784A1 (en) 2000-10-12
CA2370784C true CA2370784C (en) 2010-10-05

Family

ID=22430454

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2370784A Expired - Fee Related CA2370784C (en) 1999-04-02 2000-03-30 Endodontic fibers and methods of use therefor

Country Status (10)

Country Link
EP (2) EP1165057B1 (enExample)
JP (1) JP2002541085A (enExample)
AT (1) ATE399540T1 (enExample)
CA (1) CA2370784C (enExample)
CY (1) CY1108364T1 (enExample)
DE (1) DE60039351D1 (enExample)
DK (1) DK1165057T3 (enExample)
ES (1) ES2308975T3 (enExample)
PT (1) PT1165057E (enExample)
WO (1) WO2000059469A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019139877A1 (en) * 2018-01-10 2019-07-18 The University Of North Carolina At Chapel Hill Tigecycline for topical treatment of root canal space

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4603557B2 (ja) * 2007-01-15 2010-12-22 有限会社 ミクロデント 定量規格化培養方法
WO2010068940A2 (en) * 2008-12-12 2010-06-17 Novalar Pharmaceuticals, Inc. Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
KR20170079723A (ko) * 2015-12-31 2017-07-10 주식회사 웰나노스 치과용 약물 방출 생분해성 섬유 칩 및 그 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764377A (en) 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4892736A (en) 1983-10-07 1990-01-09 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS63303922A (ja) * 1987-06-02 1988-12-12 Rooto Seiyaku Kk 根管治療剤
US5114718A (en) * 1990-09-20 1992-05-19 The Procter & Gamble Company Sustained release compositions for treating periodontol disease
DE19813686A1 (de) * 1998-03-27 1999-09-30 Roeko Gmbh & Co Antibakteriell wirksames Mittel zur Behandlung oder zum Füllen von Wurzelkanälen und Herstellungsverfahren

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019139877A1 (en) * 2018-01-10 2019-07-18 The University Of North Carolina At Chapel Hill Tigecycline for topical treatment of root canal space

Also Published As

Publication number Publication date
EP1165057A2 (en) 2002-01-02
CY1108364T1 (el) 2014-02-12
CA2370784A1 (en) 2000-10-12
JP2002541085A (ja) 2002-12-03
WO2000059469A3 (en) 2001-03-15
DE60039351D1 (de) 2008-08-14
EP1985291A3 (en) 2012-02-15
WO2000059469A2 (en) 2000-10-12
PT1165057E (pt) 2008-09-04
WO2000059469A9 (en) 2002-02-14
ES2308975T3 (es) 2008-12-16
EP1985291A2 (en) 2008-10-29
DK1165057T3 (da) 2008-11-10
EP1165057B1 (en) 2008-07-02
ATE399540T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
US7946849B2 (en) Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
Mohammadi et al. On the local applications of antibiotics and antibiotic‐based agents in endodontics and dental traumatology
US6153210A (en) Use of locally delivered metal ions for treatment of periodontal disease
Gilad et al. Development of a clindamycin-impregnated fiber as an intracanal medication in endodontic therapy
Afkhami et al. Residual antibacterial effects of a mixture of silver nanoparticles/calcium hydroxide and other root canal medicaments against Enterococcus faecalis
Eddy et al. An in vitro evaluation of the antibacterial efficacy of chlorine dioxide on E. faecalis in bovine incisors
Ramesh et al. Local Drug Delivery in periodontal diseases.…… A Review
Srinivasan et al. Comparative study of antifungal efficacy of various endodontic irrigants with and without clotrimazole in extracted teeth inoculated with Candida albicans
Panwar et al. Local drug delivery with tetracycline fiber: An alternative to surgical periodontal therapy
CA2370784C (en) Endodontic fibers and methods of use therefor
US20120021384A1 (en) Characterization of an antibiotic imregnated delivery systems as an intracanal medicament in endodontic therapy
Jain et al. Comparative Evaluation of Antimicrobial Efficacy of Calcium Hydroxide, Triple Antibiotic Paste, and 2% Chlorhexidine Combined with 0.5% Cetrimide against Enterococcus faecalis Biofilm-Infected Dentin Model: An: In vitro: Study
Metzger et al. Immediate root canal disinfection with ultraviolet light: an ex vivo feasibility study
CA2343471C (en) Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
Al-Sabawi et al. Residual antibacterial effect of calcium hydroxide combined with chlorhexidine gel as an intracanal medicament
Gupta et al. Effectiveness of Controlled Release Chlorhexidine Chip as an Adjunctive to Scaling and Root Planning for the Treatment of Chronic Periodontitis.
Chadha et al. Local drug delivery in periodontics-current concepts and trends
Abinaya Comparative Evaluation of Antimicrobial Efficacy of Bioactive Glass, 1% Chlorhexidine Gluconate with Calcium Hydroxide and 1% Chlorhexidine Gluconate, as Intracanal Medicament in Primary Molars
Babu Minimal Inhibitory Concentration and Minimal Bactericidal Concentration of Various Intracanal Medicaments against Enterococcus faecalis: Microbial Analysis
Badgujar et al. Comparative Evaluation Of Bactericidal Efficacy Of Triple Antibiotic Paste, Modified Triple Antibiotic Paste, And Calcium Hydroxide Paste As Intracanal Medicaments Against E. Faecalis: An In Vitro Study.
Hassan et al. Evaluation of antimicrobial efficacy of calcium hydroxide with different vehicles against Enterococcus faecalis, an in vitro study
Raheja et al. Comparative efficacy of sodium hypochlorite, silver nanoparticles, and chitosan nanoparticles on gutta-percha cone disinfection and topographical changes analyzed by atomic force microscopy: An in vitro study
Sivakumar et al. Comparative Evaluation of Antimicrobial Efficacy of Three Different Intracanal Medicaments against Candida albicans: An In Vitro Study
Philip Evaluation and Comparison of Antimicrobial Efficacy of New Irrigant Chitosan Citrate on Enterococcus Faecalis and its Potency to Remove Smear Layer: An Invitro Study
Figdor From Pathogenesis To Prognosis: The Microbiology Of Endodontic Infection

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190401

MKLA Lapsed

Effective date: 20190401